These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3593544)

  • 21. [PREPARATION AND STABILITY OF CALCIUM AMINOSALICYLATE SOLUTIONS].
    VOS T; HUIZINGA T
    Pharm Weekbl; 1963 Aug; 98():719-20. PubMed ID: 14044479
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of Cu(II) in indicator reaction in volumetric drug analysis. IX. Assays of p-aminosalicylic acid salts].
    Rzeszutko W; Janik B
    Acta Pol Pharm; 1974; 31(3):331-5. PubMed ID: 4850087
    [No Abstract]   [Full Text] [Related]  

  • 23. Stability of disodium azodisalicylate (olsalazine) and metabolites in urine and faeces stored at different temperatures.
    van Hogezand RA; van Schaik A; van Hees PA; van Tongeren JH
    Eur J Drug Metab Pharmacokinet; 1988; 13(4):261-5. PubMed ID: 3243321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the stability of 5-aminosalicylic acid in tablets and suppositories by high-performance liquid chromatography.
    Cendrowska I; Drewnowska M; Grzeszkiewicz A; Butkiewicz K
    J Chromatogr; 1990 Jun; 509(1):195-9. PubMed ID: 2398126
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chromatographic study of impurities in p-aminosalicylic acid].
    COPPINI D
    Farmaco Sci; 1954; 9(10):535-8. PubMed ID: 13231887
    [No Abstract]   [Full Text] [Related]  

  • 26. Stability of 5-aminosalicylic acid and its metabolites in plasma at -20 degrees C. Formation of N-beta-D-glucopyranosyl-5-aminosalicylic acid.
    Tjørnelund J; Hansen SH
    J Chromatogr; 1991 Sep; 570(1):224-8. PubMed ID: 1797831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Colorimetric determination with 4-aminoantipyrine of M-aminophenol and of p-aminosalicylic acid].
    FRANC J
    Cesk Farm; 1955 Jan; 4(1):4-6. PubMed ID: 14364594
    [No Abstract]   [Full Text] [Related]  

  • 28. Analytical applications of p-nitrosobenzoic acid. I. Specific colorimetric determination of m-aminophenol in p-aminosalicylic acid and sodium p-aminosalicylate.
    Shih IK
    J Pharm Sci; 1971 Dec; 60(12):1853-6. PubMed ID: 5158005
    [No Abstract]   [Full Text] [Related]  

  • 29. [New colorimetric method for the determination of m-aminophenol in p-aminosalicylic acid (PAS) preparations].
    Rzeszutko W; Janik B
    Acta Pol Pharm; 1974; 31(4):469-72. PubMed ID: 4417036
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chemical structure and antitubercular activity of p-aminosalicylic acid (PAS) and of some of its derivatives].
    Solonskaia NT; Blizniukov VI
    Farm Zh; 1968; 23(4):35-41. PubMed ID: 5704030
    [No Abstract]   [Full Text] [Related]  

  • 31. [The demonstration of 5-aminosalicylic acid as a contaminant of sodium aminosalicylate].
    Vlezenbeek HJ
    Pharm Weekbl; 1966 Sep; 101(38):841-2. PubMed ID: 5980337
    [No Abstract]   [Full Text] [Related]  

  • 32. [ON TESTS FOR DETERMINING THE PURITY OF PAS SOLUTIONS].
    STEINBACH H
    Tuberkulosearzt; 1963 Dec; 17():761-5. PubMed ID: 14123195
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of vehicle on the stability of sodium aminosalicylate in liquid dosage forms.
    Blake MI; Makris KA; Tio J
    Am J Hosp Pharm; 1973 May; 30(5):441-3. PubMed ID: 4704424
    [No Abstract]   [Full Text] [Related]  

  • 34. Determination of free and acetylated 5-aminosalicylic acid in serum and urine after administration of salicylazosulphapyridine.
    Hansson KA
    Acta Pharm Suec; 1973 May; 10(2):153-5. PubMed ID: 4146997
    [No Abstract]   [Full Text] [Related]  

  • 35. Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors.
    Zhang J; Wang Q; Fang H; Xu W; Liu A; Du G
    Bioorg Med Chem; 2008 Apr; 16(7):3839-47. PubMed ID: 18304821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New method of qualitative & quantitative analysis with para-aminosalicylic acid (PAS) & its calcium, potassium & sodium salts].
    TIMMERMANN E
    Sem Med; 1958 Aug; 113(7):332-3. PubMed ID: 13602901
    [No Abstract]   [Full Text] [Related]  

  • 37. [P-aminosalicyclic acid and isonicotinic acid hydrazide in parenchymatous organs after separate and combined administration].
    AURES D; WERLE E
    Arzneimittelforschung; 1957 Apr; 7(4):252-5. PubMed ID: 13436327
    [No Abstract]   [Full Text] [Related]  

  • 38. [Spectrophotometric determination of para-aminosalicylic sodium in preparation and prescription forms].
    Koval'chuk TV
    Farm Zh; 1965; 20(3):23-8. PubMed ID: 5879269
    [No Abstract]   [Full Text] [Related]  

  • 39. [Infrared spectrum analysis of some drugs].
    SENSI P
    Boll Soc Ital Biol Sper; 1953 Apr; 29(4):592-5. PubMed ID: 13105966
    [No Abstract]   [Full Text] [Related]  

  • 40. [Decarboxylation of p-aminosalicylic acid. Kinetics and mechanisms in aqueous solution].
    Rassing JE; Andersen VS
    Dan Tidsskr Farm; 1966 Oct; 40(10):257-75. PubMed ID: 5982018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.